Northern Trust Corp Immix Biopharma, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 95,262 shares of IMMX stock, worth $213,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,262
Previous 38,914
144.8%
Holding current value
$213,386
Previous $89,000
79.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMMX
# of Institutions
25Shares Held
3.35MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$1.9 Million0.49% of portfolio
-
Cable Car Capital LLC San Francisco, CA779KShares$1.75 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.56 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$907,20011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$360,0620.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $31.2M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...